We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$17B
AUM Growth
+$1.75B
Cap. Flow
+$808M
Cap. Flow %
4.76%
Top 10 Hldgs %
16.45%
Holding
2,292
New
159
Increased
1,096
Reduced
891
Closed
119
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SI
1901
DELISTED
Silvergate Capital Corporation
SI
$418K ﹤0.01%
+3,690
New +$418K
SAH icon
1902
Sonic Automotive
SAH
$2.74B
$417K ﹤0.01%
9,312
+3,748
+67% +$182K
FPL
1903
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$417K ﹤0.01%
70,623
-28,016
-28% -$160K
DAY
1904
DELISTED
Dayforce
DAY
$416K ﹤0.01%
4,340
+378
+10% +$34.1K
KKR icon
1905
KKR & Co
KKR
$94.9B
$415K ﹤0.01%
7,009
-2,370
-25% -$132K
RDFN
1906
DELISTED
Redfin
RDFN
$415K ﹤0.01%
6,549
+905
+16% +$55.3K
STRA icon
1907
Strategic Education
STRA
$1.89B
$413K ﹤0.01%
5,429
-1,029
-16% -$82.1K
TTEC icon
1908
TTEC Holdings
TTEC
$128M
$413K ﹤0.01%
4,004
-24
-0.6% -$2.49K
JRI icon
1909
Nuveen Real Asset Income & Growth Fund
JRI
$348M
$412K ﹤0.01%
25,696
-20,000
-44% -$313K
CDXS icon
1910
Codexis
CDXS
$156M
$409K ﹤0.01%
18,057
-3,293
-15% -$71.4K
SLP icon
1911
Simulations Plus
SLP
$371M
$409K ﹤0.01%
7,451
-219
-3% -$12.6K
SUPN icon
1912
Supernus Pharmaceuticals
SUPN
$2.73B
$409K ﹤0.01%
13,293
-1,255
-9% -$38.5K
TEF
1913
DELISTED
Telefonica
TEF
$406K ﹤0.01%
92,688
+64,692
+231% +$280K
PKO
1914
DELISTED
Pimco Income Opportunity Fund
PKO
$405K ﹤0.01%
15,215
-2,752
-15% -$74K
YELP icon
1915
Yelp
YELP
$1.41B
$398K ﹤0.01%
+9,950
New +$395K
LPLA icon
1916
LPL Financial
LPLA
$28.3B
$397K ﹤0.01%
2,937
-1,143
-28% -$166K
GMED icon
1917
Globus Medical
GMED
$10.9B
$395K ﹤0.01%
5,101
-5,398
-51% -$384K
PLAN
1918
DELISTED
Anaplan, Inc.
PLAN
$395K ﹤0.01%
7,419
-712
-9% -$39.6K
AMBA icon
1919
Ambarella
AMBA
$3.59B
$393K ﹤0.01%
3,687
-2,364
-39% -$234K
SKYW icon
1920
Skywest
SKYW
$4.6B
$391K ﹤0.01%
9,085
+3,658
+67% +$180K
VCSH icon
1921
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$388K ﹤0.01%
4,694
-1,817
-28% -$150K
ONTO icon
1922
Onto Innovation
ONTO
$13.7B
$387K ﹤0.01%
5,295
-622
-11% -$42.7K
BEKE icon
1923
KE Holdings
BEKE
$18.7B
$386K ﹤0.01%
+8,100
New +$414K
FCF icon
1924
First Commonwealth Financial
FCF
$2.19B
$385K ﹤0.01%
27,360
+11,002
+67% +$162K
AVNS
1925
DELISTED
Avanos Medical
AVNS
$384K ﹤0.01%
10,550
-15,673
-60% -$648K

Similar funds

Guggenheim Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Guggenheim Capital held 2,292 positions worth $17B, up 12% from $15.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Guggenheim Capital deployed $808M of net new capital in Q2 2021, opening 159 new positions and adding to 1,096 existing holdings. Its largest new stake was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was RXR Acquisition Corp. Units, an estimated $32.6M trimmed.

  • Guggenheim Capital's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.
  • Guggenheim Capital added most to Apple in Q2 2021, an estimated $49.1M increase.
  • Guggenheim Capital's biggest Q2 2021 reduction was RXR Acquisition Corp. Units, cutting an estimated $32.6M.
  • Guggenheim Capital fully exited KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant in Q2 2021, selling an estimated $153M.
  • Guggenheim Capital's ten largest holdings make up 16% of its $17B portfolio in Q2 2021.
  • Guggenheim Capital opened 159 new positions and closed 119 in Q2 2021.
  • Guggenheim Capital's portfolio value rose 12% quarter-over-quarter to $17B.

Based on Guggenheim Capital's 13F filing for Q2 2021, filed 13 Aug 2021.